DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Important Information on Fraudulent Emails to Practitioners
August 1, 2023

The Department of Health, Division of Medical Quality Assurance, is warning Florida health care practitioners about fraudulent emails that have been received by multiple licensees. Continue reading


New Legislation Impacting Your Profession
June 28, 2023

Click here to view a full list of bill summaries from the 2023 Florida Legislative Session that may impact your profession. Continue reading